
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center; Departments of 2 Medicine and 3 Genome Sciences, University of Washington, Seattle, Washington; and 4 Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts
Requests for reprints: Thomas Paulson, Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue C1-157, PO Box 19024, Seattle, WA 98109-1024. Phone: 206-667-4615; Fax: 206-667-6132; E-mail: tpaulson{at}fhcrc.org.
Purpose: Neosquamous epithelium (NSE) can arise within Barrett's esophagus as a consequence of medical or surgical acid reduction therapy, as well as after endoscopic ablation. Morphologic studies have suggested that NSE can develop from adjacent squamous epithelium, submucosal gland ducts, or multipotent progenitor cell(s) that can give rise to either squamous or Barrett's epithelium, depending on the luminal environment. The cells responsible for Barrett's epithelium self-renewal are frequently mutated during neoplastic progression. If NSE arises from the same cells that self-renew the Barrett's epithelium, the two tissues should be clonally related and share genetic alterations; if NSE does not originate in the self-renewing Barrett's, NSE and Barrett's esophagus should be genetically independent.
Experimental Design: We isolated islands of NSE and the surrounding Barrett's epithelium from 20 patients by microdissection and evaluated each tissue for genetic alterations in exon 2 of CDKN2A or exons 5 to 9 of the TP53 gene. Nine patients had p16 mutations and 11 had TP53 mutations within the Barrett's epithelium.
Results: In 1 of 20 patients, a focus of NSE had a 146 bp deletion in p16 identical to that found in surrounding Barrett's epithelium. The NSE in the remaining 19 patients was wild-type for p16 or TP53.
Conclusion: Our mutational data support the hypothesis that, in most circumstances, NSE originates in cells different from those responsible for self-renewal of Barrett's epithelium. However, in one case, NSE and Barrett's epithelium seem to have arisen from a progenitor cell that was capable of differentiating into either intestinal metaplasia or NSE.
This article has been cited by other articles:
![]() |
R. C Fitzgerald Dissecting out the genetic origins of Barrett's oesophagus Gut, August 1, 2008; 57(8): 1033 - 1034. [Full Text] [PDF] |
||||
![]() |
S J Leedham, S L Preston, S A C McDonald, G Elia, P Bhandari, D Poller, R Harrison, M R Novelli, J A Jankowski, and N A Wright Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus Gut, August 1, 2008; 57(8): 1041 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C Maley Open questions in oesophageal adenocarcinogenesis Gut, July 1, 2007; 56(7): 897 - 898. [Full Text] [PDF] |
||||
![]() |
C.-L. Chang, P. Lao-Sirieix, V. Save, G. De La Cueva Mendez, R. Laskey, and R. C Fitzgerald Retinoic acid-induced glandular differentiation of the oesophagus Gut, July 1, 2007; 56(7): 906 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
R C Fitzgerald Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, December 1, 2006; 55(12): 1810 - 1820. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |